Literature DB >> 20833542

Peripheral but crucial: a hydrophobic pocket (Tyr(706), Leu(337), and Met(336)) for potent and selective inhibition of neuronal nitric oxide synthase.

Fengtian Xue1, Huiying Li, Jianguo Fang, Linda J Roman, Pavel Martásek, Thomas L Poulos, Richard B Silverman.   

Abstract

Selective inhibition of the neuronal isoform of nitric oxide synthase (nNOS) over endothelial nitric oxide synthase (eNOS) and inducible nitric oxide synthase (iNOS) has become a promising strategy for the discovery of new therapeutic agents for neurodegenerative diseases. However, because of the high sequence homology of different isozymes in the substrate binding pocket, developing inhibitors with both potency and excellent isoform selectivity remains a challenging problem. Herein, we report the evaluation of a recently discovered peripheral hydrophobic pocket (Tyr(706), Leu(337), and Met(336)) that opens up upon inhibitor binding and its potential in designing potent and selective nNOS inhibitors using three compounds, 2a, 2b, and 3. Crystal structure results show that inhibitors 2a and 3 adopted the same binding mode as lead compound 1. We also found that hydrophobic interactions between the 4-methyl group of the aminopyridine ring of these compounds with the side chain of Met(336), as well as the π-π stacking interaction between the pyridinyl motif and the side chain of Tyr(706) are important for the high potency and selectivity of these nNOS inhibitors.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20833542      PMCID: PMC2952696          DOI: 10.1016/j.bmcl.2010.08.096

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  21 in total

1.  Computer modeling of selective regions in the active site of nitric oxide synthases: implication for the design of isoform-selective inhibitors.

Authors:  Haitao Ji; Huiying Li; Mack Flinspach; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2003-12-18       Impact factor: 7.446

2.  Structures of nitric oxide synthase isoforms complexed with the inhibitor AR-R17477 suggest a rational basis for specificity and inhibitor design.

Authors:  Roman Fedorov; Ryan Vasan; Dipak K Ghosh; Ilme Schlichting
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-07       Impact factor: 11.205

3.  Nitric-oxide synthase assays.

Authors:  J M Hevel; M A Marletta
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

Review 4.  Role of nitric oxide in Parkinson's disease.

Authors:  Li Zhang; Valina L Dawson; Ted M Dawson
Journal:  Pharmacol Ther       Date:  2005-07-07       Impact factor: 12.310

5.  Use of TLS parameters to model anisotropic displacements in macromolecular refinement.

Authors:  M D Winn; M N Isupov; G N Murshudov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2001-01

Review 6.  Design of isoform-selective inhibitors of nitric oxide synthase.

Authors:  B R Babu; O W Griffith
Journal:  Curr Opin Chem Biol       Date:  1998-08       Impact factor: 8.822

Review 7.  Mitochondrial contributions to tissue damage in stroke.

Authors:  Neil R Sims; Michelle F Anderson
Journal:  Neurochem Int       Date:  2002-05       Impact factor: 3.921

Review 8.  Nitric oxide synthase inhibitors for the treatment of chronic tension-type headache.

Authors:  Messoud Ashina
Journal:  Expert Opin Pharmacother       Date:  2002-04       Impact factor: 3.889

Review 9.  Design of selective neuronal nitric oxide synthase inhibitors for the prevention and treatment of neurodegenerative diseases.

Authors:  Richard B Silverman
Journal:  Acc Chem Res       Date:  2009-03-17       Impact factor: 22.384

10.  Decreased neuronal nitric oxide synthase messenger RNA and somatostatin messenger RNA in the striatum of Huntington's disease.

Authors:  P J Norris; H J Waldvogel; R L Faull; D R Love; P C Emson
Journal:  Neuroscience       Date:  1996-06       Impact factor: 3.590

View more
  14 in total

1.  Hydrophilic, Potent, and Selective 7-Substituted 2-Aminoquinolines as Improved Human Neuronal Nitric Oxide Synthase Inhibitors.

Authors:  Anthony V Pensa; Maris A Cinelli; Huiying Li; Georges Chreifi; Paramita Mukherjee; Linda J Roman; Pavel Martásek; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2017-08-04       Impact factor: 7.446

2.  Intramolecular hydrogen bonding: a potential strategy for more bioavailable inhibitors of neuronal nitric oxide synthase.

Authors:  Kristin Jansen Labby; Fengtian Xue; James M Kraus; Haitao Ji; Jan Mataka; Huiying Li; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  Bioorg Med Chem       Date:  2012-02-07       Impact factor: 3.641

3.  Role of an isoform-specific substrate access channel residue in CO ligand accessibilities of neuronal and inducible nitric oxide synthase isoforms.

Authors:  Changjian Feng; Weihong Fan; Dipak K Ghosh; Gordon Tollin
Journal:  Biochim Biophys Acta       Date:  2010-12-10

4.  Phenyl Ether- and Aniline-Containing 2-Aminoquinolines as Potent and Selective Inhibitors of Neuronal Nitric Oxide Synthase.

Authors:  Maris A Cinelli; Huiying Li; Anthony V Pensa; Soosung Kang; Linda J Roman; Pavel Martásek; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2015-10-27       Impact factor: 7.446

5.  Symmetric double-headed aminopyridines, a novel strategy for potent and membrane-permeable inhibitors of neuronal nitric oxide synthase.

Authors:  Fengtian Xue; Jianguo Fang; Silvia L Delker; Huiying Li; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2011-03-16       Impact factor: 7.446

6.  Nitrile in the Hole: Discovery of a Small Auxiliary Pocket in Neuronal Nitric Oxide Synthase Leading to the Development of Potent and Selective 2-Aminoquinoline Inhibitors.

Authors:  Maris A Cinelli; Huiying Li; Georges Chreifi; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2017-04-19       Impact factor: 7.446

7.  Acid-Facilitated Debenzylation of N-Boc, N-Benzyl Double Protected 2-Aminopyridinomethylpyrrolidine Derivatives.

Authors:  Haitao Ji; Qing Jing; Jinwen Huang; Richard B Silverman
Journal:  Tetrahedron       Date:  2011-12-13       Impact factor: 2.457

8.  Structural basis for isoform-selective inhibition in nitric oxide synthase.

Authors:  Thomas L Poulos; Huiying Li
Journal:  Acc Chem Res       Date:  2012-10-02       Impact factor: 22.384

Review 9.  Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain.

Authors:  Paramita Mukherjee; Maris A Cinelli; Soosung Kang; Richard B Silverman
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

10.  First Contact: 7-Phenyl-2-Aminoquinolines, Potent and Selective Neuronal Nitric Oxide Synthase Inhibitors That Target an Isoform-Specific Aspartate.

Authors:  Maris A Cinelli; Cory T Reidl; Huiying Li; Georges Chreifi; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2020-04-17       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.